BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vertos Medical Inc. Release: New Study Data Demonstrate Effectiveness of Back Treatment Mild® Over Two Year Period


3/5/2013 9:23:54 AM

ALISO VIEJO, Calif., March 4, 2013 /PRNewswire-USNewswire/ -- The mild® procedure, a minimally-invasive outpatient procedure designed to provide relief to patients suffering with the common back condition lumbar spinal stenosis (LSS), demonstrates durable pain relief and improvement in mobility over a two year period according to new study data. The study monitored 45 patients at 11 sites during a two year period and is currently the longest multi-center study in publication on the mild procedure.

Data from the study showed a statistically significant improvement in pain relief and physical function for patients treated with mild, which is consistent with the positive results published in more than 15 scientific articles. The study was authored by Dr. Bohdan Chopko and published in the Clinical Journal of Pain.

At two years, these study patients reported a statistically significant reduction in pain and an improvement in mobility and physical function.* Patient progress was documented at multiple follow-ups over the two year period and patients reported, "major improvement occurred by 1-week follow-up and showed no difference between each subsequent follow-up, signifying considerable stability and durability of the initial result over time." No major device or intra-procedural adverse events were reported in the study.

LSS is caused by the compression of the nerves in the spinal canal, which can lead to pain and numbness in the lower back, buttocks, or upper legs as well as reduced mobility. mild alleviates the compression by restoring space in the spinal canal with precision instruments through an incision the size of a baby aspirin. The procedure is performed on an outpatient basis and does not require general anesthesia or stitches.

Multiple studies have confirmed that mild patients are experiencing positive effects with a low risk of major complications. To read patients' stories and find more information about mild please visit www.mildprocedure.com.

*Pain was measured by the Visual Analog Scale (VAS) and mobility and functionality was measured by the Oswestry Disability Index (ODI) and the Zurich Claudication Questionnaire (ZCQ).

About mild
mild is a safe procedure that can help patients diagnosed with lumbar spinal stenosis (LSS) stand longer and walk farther with less pain. It is a short outpatient procedure performed through an incision the size of a baby aspirin that requires no general anesthesia, no implants and no stitches. Its efficacy and safety have been demonstrated in 11 clinical trials and 16 physician reviewed clinical journal articles. For more information, visit www.mildprocedure.com.

About Vertos Medical Inc.
Vertos Medical is a leader in the treatment of patients suffering with lumbar spinal stenosis (LSS), a degenerative, age-related narrowing of the lower spinal canal. Its proprietary technologies include mild, which offers an outpatient, minimally invasive, fluoroscopically guided therapeutic treatment of LSS. For more information, visit www.Vertosmed.com.

SOURCE Vertos Medical Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES